Experimental model and immunohistochemical analyses of U87 human glioblastoma cell xenografts in immunosuppressed rat brains

Anticancer Research

Volumn 26, Issue 4 B, 2006, Pages 2887-2900

  Strojnik, Tadej ^a   Kavalar, Rajko ^a   Lah, Tamara T ^b  

^a UNIVERSITY MEDICAL CENTRE MARIBOR   (Slovenia)

^b NATIONAL INSTITUTE OF BIOLOGY   (Slovenia)

Author keywords

Angiogenesis; Dedifferentiation; Experimental cancer rat model; Glioma; Invasion; Tumour markers; U87 spheroids

Indexed keywords

BLOOD CLOTTING FACTOR 8; CATHEPSIN B; CATHEPSIN L; CHLORDANE; CYCLOSPORIN A; GLIAL FIBRILLARY ACIDIC PROTEIN; KALLIKREIN; KI 67 ANTIGEN; NESTIN; PROTEIN MUSASHI; PROTEIN P53; PROTEIN S 100; SYNAPTOPHYSIN; TUMOR MARKER; UNCLASSIFIED DRUG; VIMENTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN; BRAIN TUMOR; CANCER CELL; CANCER INVASION; CARCINOGENESIS; CELL PROLIFERATION; CELL SUSPENSION; CONTROLLED STUDY; CORRELATION ANALYSIS; EXPERIMENTAL MODEL; GLIOBLASTOMA; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; MESENCHYME CELL; NEUROPATHOLOGY; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; TISSUE CULTURE; TRANSPLANTATION; TUMOR GROWTH; XENOGRAFT;

ANIMALS; BRAIN NEOPLASMS; CELL GROWTH PROCESSES; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; GLIOBLASTOMA; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOHISTOCHEMISTRY; NEOPLASM TRANSPLANTATION; RATS; RATS, WISTAR; SPHEROIDS, CELLULAR; TRANSPLANTATION, HETEROLOGOUS;

EID: 33746779437     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Wechsler W, Szymas J, Bilzer T and Hossmann KA: Experimental transplantation gliomas in the adult cat brain. Aca Neurochirurg 98: 77-89, 1989.
2. Pilkington GJ, Bjerkvig R, De Ridder L and Kaaijk P: In vitro and in vivo models for the study of brain tumour invasion. Anticancer Res 17: 4107-4110, 1997.
3. Brem H and Sawaya R: Brain tumours: general considerations. In: Youmans Neurological Surgery, 5th ed., Winn HR (ed.). Vol 1. New York, W.B. Saunders, pp. 659-660, 2004.
4. Bressler J, Smith BH and Kornblith PL: Tissue culture techniques in the study of human gliomas. In: Neurosurgery. Wilkins RH (ed.). New York, Mc Graw Hill, pp. 542-548, 1985.
5. Bjerkvig R, Tønnesen A, Laerum OD and Backlund EO: Multicellular tumour spheroids from human gliomas maintained in organ culture. J Neurosurg 72: 463-475, 1990.
6. Engebraaten O, Bjerkvig R, Lund-Johansen M, Wester K, Pedersen P-H, Mørk S, Backlund E-O and Laerum OD: Interaction between human brain tumour biopsies and fetal rat brain tissue in vitro. Acta Neuropathol (Berl) 81: 130-140, 1990.
7. Engebraaten O, Hjortland GO, Hirschberg H and Fodstad O: Growth of precultured human glioma specimens in nude rat brain. J Neurosurg 90: 125-132, 1999.
8. Fogh J, Wright WC and Loveless JD: One hundred and twenty-seven cultured human tumour cell lines producing tumours in nude mice. J Natl Cancer Inst 59: 221-226, 1977.
9. Ponten J and Macintyre EH: Long-term culture of normal and neoplastic human glia. Acta Pathol Microbiol Scand 74: 465-486, 1968.
10. Olopade OI, Jenkins RB, Ransom DT, Malik K, Pomykala H, Nabori T, Cowan JM, Rowler JD and Diaz MO: Molecular analysis of deletions of the short arm of chromosome 9 in human gliomas. Cancer Res 52: 2523-2529, 1992.
11. Sabattini E, Bisgaard K, Ascani S, Poggi S, Piccioli M, Ceccarelli C, Fieri F, Fraternali-Orcioni G and Piled SA: The EnVision++system: a new immunohistochemical method for diagnostics and research. Critical comparison with the APAAP, ChemMate, CSA, LABC, and SABC techniques. J Clin Pathol 51: 506-511, 1998.
12. Li R, Heydon K, Hammond ME, Grignon DJ, Roach M, Wolkov HB, Sandler HM, Shipley WU and Pollack A: Ki-67 staining index predicts distant metastasis and survival in locally advanced prostate cancer treated with radiotherapy. Clin Cancer Res 10: 4118-4124, 2004.
13. Takeuchi H, Ozawa S, Ando N, Kitagawa Y, Ueda M and Kitajima M: Cell-cycle regulators and the Ki-67 labeling index can predict the response to chemoradiotherapy and the survival of patients with locally advanced squamous cell carcinoma of the esophagus. Ann Surg Oncol 10: 792-800, 2003.
14. Almqvist PM, Mah R, Lendahl U, Jacobsson B and Hendson G: Immunohistochemical detection of nestin in pediatric brain tumours. J Histochem Cytochem 50: 147-158, 2002.
15. Dietrich P-Y, Walker PR and De Tribolet N: Aspects of immunology applicable to brain tumour pathogenesis and treatment. In: Youmans Neurological Surgery. Winn HR (ed.). 5th ed., Vol 1. New York, W.B. Saunders, pp. 887-897, 2004.
16. Hossmann K-A, Wechsler W and Wilmes F: Experimental peritumourous edema. Morphological and pathophysiological observations. Acta Nuropathol 45: 195-203, 1979.
17. Kleihues P and Cavenee WK: Pathology and genetics of tumours of the nervous system. WHO Classification of Tumours. Lyon: IARC Press, pp. 9-54, 2000.
18. Badie B and Schartner J: Role of microglia in glioma biology. Microscop Res Techn 54: 106-113, 2001.
19. Mueller MM and Fusenig NE: Friends or foes - bipolar effects of the tumour stroma in cancer. Nat Rev Cancer 4: 839-849, 2004.
20. Scott R, Hall P and Haldane J: A comparison of immunohistochemical markers of cell proliferation with experimentally determined growth fraction. J Clin Pathol 165: 173-178, 1991.
21. Wilson G, Saunders M and Dische S: Direct comparison of bromodeoxyuridine and Ki-67 labeling indices in human tumours. Cell Prolif 29: 141-152, 1996.
22. Halvorsen OJ, Haukaas S, Hoisaeter PA and Akslen LA: Maximum Ki-67 staining in prostate cancer provides independent prognostic information after radical prostatectomy. Anticancer Res 21: 4071-4076, 2001.
23. Dahl D, Rueger DC and Bignami A: Vimentin, the 57,000 molecular weight protein of fibroblast filaments, is the major cytoskeletal component in immature glia. Eur J Cell Biol 90: 191-196, 1981.
24. Dahl D: The vimentin-GFAP protein transition in rat neuroglia cytoskeleton occurs at the time of myelination. J Neurosci Res 6: 741-748, 1981.
25. Yung WKA, Luna M and Borit A: Vimentin and glial fibrillary acidic protein in human brain tumours. J Neurooncol 3: 35-38, 1985.
26. Takahashi K, Isobe T and Ohtsuki Y: Immunohistochemical study of the distribution of and subunits of S100 protein in human neoplasm and normal tissues. Virchows Arch B 45: 385-396, 1984.
27. Kahn HJ, Marks A and Thom H: Role of antibody of S100 protein in diagnostic pathology. Am J Clin Pathol 79: 341-347, 1983.
28. Bigner DD, Bigner SH, Ponten J, Westermark B, Mahaley MS Jr, Rouslahti E, Herschman H, Eng LF and Wikstrand CJ: Heterogeneity of genotypic and phenotypic characteristics of fifteen permanent cell lines derived from human gliomas. J Neuropathol Exp Neurol 40: 201-229, 1981.
29. Jacque CM, Kujas M, Poreau A, Raoul M, Collier P, Racadot J and Baumann N: GFA and S100 protein levels as an index for malignancy in human gliomas and neurinomas. JNCI 62: 479-483, 1979.
30. Lazarides E: Intermediate filaments: a chemically heterogeneous, developmentally regulated class of proteins. Annu Rev Biochem 51: 219-250, 1982.
31. Dahlstrand J, Collins VP and Lendahl U: Expression of the Class VI intermediate filament nestin in human central nervous system tumours. Cancer Res 52: 5334-5341, 1992.
32. Strojnik T: Immunohistochemical detection of nestin and musashi in tumour and endothelial cells and their role as possible prognostic factor for survival in glioma patients. Anticancer Res 24(5D): 3642, 2004. (Abstracts of the Seventh International Conference of Anticancer Research, Corfu, Greece, October 25-30, 2004.
33. Okano H, Imai T and Okabe M: Musashi: a translational regulator of cell fate. J Cell Science 115: 1355-1359, 2002.
34. McKeever PE: Insights about brain tumours gained through immunohistochemistry and in situ hybridization of nuclear and phenotypic markers. J Histochem Cytochem 46: 585-594, 1998.
35. Levicar N, Nuttall RK and Lah TT: Proteases in brain tumour progression. Acta Neurochir (Wien) 145: 825-838, 2003.
36. Demchik LL, Sameni M, Nelson K, Mikkelsen T and Sloane BF: Cathepsin B and glioma invasion. Int J Dev Neurosci 17(5-6): 483-494, 1999.
37. Strojnik T, Kos J, Zidanik B, Golouh R and Lah T: Cathepsin B immunohistochemical staining in tumour and endothelial cells is a new prognostic factor for survival in patients with brain tumours. Clin Cancer Res 5: 559-567, 1999.
38. Zajc I, Sever N, Bervar A and Lah T: Expression of cysteine peptidase cathepsin L and its inhibitors stefins A and B in relation to tumorigenicity of breast cancer cell lines. Cancer Lett 187: 185-190, 2002.
39. Bervar A, Zajc I, Sever N, Katunuma N, Sloane BF and Lah TT: Invasiveness of transformed human breast epithelial cell lines is related to cathepsin B and inhibited by cysteine proteinase inhibitors. Biol Chem 384: 447-455, 2003.
40. Sivaparvathi M, Sawaya R, Wang SW, Rayford A, Yamamoto M, Liotta LA, Nicolson G and Rao JS: Overexpression and localisation of Cat B during the progression of human gliomas. Clin Exp Metastasis 13: 49-56, 1995.
41. Strojnik T, Kavalar R, Trinkaus M and Lah T: Cathepsin L in glioma progression: comparison with cathepsin B. Cancer Det Prev 29: 448-455, 2005.
42. Hulette CM, Downev BT and Burger PC: Macrophage markers in diagnostic neuropathology. Am J Surg Pathol 16: 493-499, 1992.
43. Badie B, Schartner JBS, Klaver J and Vorpahl J: In vitro modulation of microglia motility by glioma cells is mediated by hepatocyte growth factor/scatter fator. Neurosurg 44: 1077-1082, 1999.
44. McComb RD, Jones TR and Pizzo SV: Specificity and sensitivity of immunohistochemical detection of factor VIII/von Willebrand factor antigen in formalin-fixed paraffin-embedded tissue. J Histochem Cytochem 30: 371-377, 1982.
45. Borgono CA and Diamandis EP: The emerging roles of human tissue kallikreins in cancer. Nature Rev Cancer 4: 876-890, 2004.
46. Borgono CA, Michael IP and Diamandis EP: Human tissue kallikreins: physiologic roles and applications in cancer. Mol Cancer Res 2: 257-280, 2004.
47. Raidoo DM, Snyman C, Narotam PK, Muller R and Bhoola KD: Human cerebral tissue kallikrein. Asia Pac J Pharmacol 10 (Suppl 1): S72, 1995.
48. Diamandis EP, Yousef GM and Olsson AY: An update on human and mouse glandular kallikreins. Clin Biochem 37: 258-260, 2004.